A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for Overweight
60 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025
Southern Endocrinology Associates
Clinical research site in Mesquite, Texas · 3500 IH-30 BUIDLING D, SUITE 203, MESQUITE, TX 75150 · (972) 682-5700
As of September 2026, 12 paid clinical trials are recruiting at Southern Endocrinology Associates in Mesquite, Texas. Active studies at this site cover conditions such as Type 2 Diabetes, Cardiovascular Diseases and Diabetes Mellitus, Type 2. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at Southern Endocrinology Associates? We'll email you when one opens.
Recruiting clinical trials at Southern Endocrinology Associates (12)
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
for Severe Hypertriglyceridemia
29 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07269210·Phase 2·Recruiting·Listed Dec 2025
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
for Metabolic Dysfunction-Associated Steatotic Liver Disease
142 locations incl. Tuscaloosa
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for Diabetes Mellitus, Type 2
204 locations incl. Anniston
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07064473·Phase 3·Recruiting·Listed Jul 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
194 locations incl. Alexander City
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
for Atherosclerotic Cardiovascular Disease
138 locations incl. Daphne
Sponsor: Amgen
Sex: All·Age: 45 - 99
Code: NCT07037433·Phase 3·Recruiting·Listed Jun 2025
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for Type 2 Diabetes
25 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT06897475·Phase 2·Recruiting·Listed Mar 2025
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for Type 1 Diabetes Mellitus With Hypoglycemia
37 locations incl. Birmingham
Sponsor: Zucara Therapeutics Inc.
Sex: All·Age: 18 - 75
Code: NCT05762107·Phase 2·Recruiting·Listed Mar 2023
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for Hypothyroidism
130 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 18 - 75
Code: NCT06345339·Phase 2, Phase 3·Recruiting·Listed Apr 2024
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
for Graves' Disease
17 locations incl. Orange
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT07570316·Phase 3·Recruiting·Listed May 2026
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
for Type 2 Diabetes
89 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07754461·Phase 3·Recruiting·Listed Aug 10, 2026
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for Obesity
68 locations incl. Anniston
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07684235·Phase 3·Recruiting·Listed Jul 6, 2026
Get new-trial alerts for Southern Endocrinology Associates
We'll email you whenever a new clinical trial starts recruiting at this research site in Mesquite, TX. Unsubscribe anytime.
More research sites in Mesquite
- Southwest Rheumatology Research (7 trials)
- Southern Endocrinology Associates PA (4 trials)
- GSK Investigational Site (3 trials)
- SMS Clinical Research LLC (3 trials)
- SMS Clinical Research (3 trials)
- SMS Clinical Research, LLC (2 trials)
- SMS Clinical Research, LLC - 400 W. Kearney St (2 trials)
- AURORA-1 Clinical Site (1 trial)
- AURORA-2 Clinical Site (1 trial)
- Artiva Investigational (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Mesquite, TX · Texas clinical trials